Positions
- Professor
-
Medicine-Infectious Disease
ÌÇÐÄÊÓƵ of Medicine
Houston, TX, US
- Chief, Infectious Diseases Section
-
Michael E. DeBakey VAMC
Houston, Texas
Addresses
- Infectious Diseases Section (Office)
-
Michael E. DeBakey VAMC
Room 4B-370; MS 111G
Houston, TX, 77030
United States
Phone: (713) 794-8856
maria.rodriguez-barradas2@va.gov
Education
- Fellowship at ÌÇÐÄÊÓƵ Of Medicine
- 12/1993 - Houston, TX, United States
- HIV Medicine
- Clinical Fellowship at ÌÇÐÄÊÓƵ Of Medicine
- 10/1992 - Houston, TX, United States
- Infectious Diseases
- Residency at Central University of Venezuela
- 12/1988 - Caracas, Venezuela
- Internal Medicine
- MD from Central University Of Venezuela
- 11/1983 - Caracas, Venezuela
Certifications
- Board Certified
- ABIM-Internal Medicine
- Board Certified
- ABIM-Infectious Diseases
Websites
Infectious Diseases Section Research Laboratory
ÌÇÐÄÊÓƵ of Medicine
VIICTR Research Database
Funding
-
1. Alcohol and multisubstance use in the veterConsortium to improve OutcoMes in HIV/AIDS, Alcohol, Aging, and multi-Substance use (COMpAAAS)
#1-U01-AA-020790 - (09/01/2017 - 08/31/2021)
- Grant funding from NIH AAA
- Current projects under this grant: a. Observation Study: Veterans Aging Cohort Study: Survey and electronic cohort. b. Integrated stepped care for unhealthy alcohol use in HIV. c. Intervention Study: Financial Incentives, Randomization with Stepped Treatment (FIRST) trial. d. Intervention Study: MASH Medication Reconciliation study (polypharmacy).
-
SUPERNOVA
#CDC 110FED1009332 - (10/01/2015 - 03/31/2021)
- Grant funding from CDC
- Active surveillance to quantify the burden of viral gastroenteritis and acute respiratory infections including COVID in US Veterans Affairs (VA) patient population.
-
Reprieve
- $261,468.00 (06/01/2014 - 05/31/2021)
- Grant funding from NIH
- REPRIEVE (A5332): Randomized trial to prevent vascular events in HIV. ACTG/NIH. Role: MEDVAMC PI
-
TRAP-LRTI
- (01/06/2016 - 12/31/2020)
- Grant funding from VTEU
- TRAP-LRTI (Protocol 15-0020): Targeted reduction of antibiotics using procalcitonin in a multi-center randomized, blinded, placebo-controlled non-inferiority study of infection (LRTI) and a procalcitonin level of <0.1 ng/ml. 6/2016-6/2018. Baylor VTEU Protocol. Role: Houston PI.
Languages
Spanish
to edit your profile